Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A perspective on telmisartan and cardiovascular risk.

Reviews in cardiovascular medicine - 1 Jan 2007

Giles Thomas D

Abstract excerpt

The angiotensin receptor blockers (ARBs) are well established as safe and effective in the treatment of arterial hypertension. Telmisartan is an ARB with potent blood-pressure lowering effects. It has a long terminal half-life of about 24 hours (the longest of any of the ARBs), which enables it to sustain blood pressure reductions in the early morning hours, after the previous morning dosing. Unlike the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Angiotensin II Type 1 Receptor Blockers
Share to Benzimidazoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Benzoates

Share to Clinical Trials as Topic

Share to Half-Life

Share to Peripheral Vascular Diseases

Share to Stroke Volume

Source

Identifiers

PMID: 17938615

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

A perspective on telmisartan and cardiovascular risk.PMID 17938615Read ↗

Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartan.Semantic proximity Read ↗

Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients.Semantic proximity Read ↗

Treating prehypertension: a review of the evidence.Semantic proximity Read ↗

The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS.Semantic proximity Read ↗

No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects.Semantic proximity Read ↗

Cardiovascular Risk Assessment.Semantic proximity Read ↗

Pharmacogenomics and management of cardiovascular disease.Semantic proximity Read ↗

Renin–angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.